Increasing use of gonadotropin‐releasing hormone agonists for the treatment of localized prostate carcinoma
Vahakn B. Shahinian(University of Michigan–Ann Arbor), James S. Goodwin(John Sealy Hospital), Eduardo Orihuela(The University of Texas Medical Branch at Galveston), Yong‐Fang Kuo(John Sealy Hospital), Jean L. Freeman(John Sealy Hospital)
Cited by 323
Related Papers
Risk of Fracture after Androgen Deprivation for Prostate Cancer
|New England Journal of Medicine|2005|1.4k
Effect of aging on respiratory system physiology and immunology
|Clinical Interventions in Aging|2006|1k
Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.
|The Journal of Experimental Medicine|1977|795
Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer
|Journal of Clinical Oncology|2007|630
Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer
|JNCI Journal of the National Cancer Institute|2005|558